Journey Medical Corp (DERM)
3.51
-0.11
(-3.04%)
USD |
NASDAQ |
May 01, 11:02
Journey Medical Free Cash Flow: 0.24M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.24M |
| September 30, 2023 | 12.92M |
| June 30, 2023 | -13.10M |
| March 31, 2023 | -20.37M |
| December 31, 2022 | -33.53M |
| Date | Value |
|---|---|
| September 30, 2022 | -34.10M |
| June 30, 2022 | -28.52M |
| March 31, 2022 | -2.658M |
| December 31, 2021 | -2.181M |
Free Cash Flow Range, Past 5 Years
-34.10M
Minimum
Sep 2022
12.92M
Maximum
Sep 2023
-13.48M
Average
-13.10M
Median
Jun 2023
Free Cash Flow Benchmarks
| Fortress Biotech Inc | -136.32M |
| Puma Biotechnology Inc | 14.37M |
| GT Biopharma Inc | -8.852M |
| FibroGen Inc | -317.54M |
| Outlook Therapeutics Inc | -47.10M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -16.52M |
| Cash from Financing (Quarterly) | 19.21M |
| Free Cash Flow Per Share (Quarterly) | -0.8549 |
| Free Cash Flow to Equity (Quarterly) | -31.14M |
| Free Cash Flow to Firm (Quarterly) | -16.52M |
| Free Cash Flow Yield | 0.36% |